Circle Wealth Management’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Sell
3,725
-514
-12% -$33.6K ﹤0.01% 235
2026
Q1
$241K Buy
4,239
+80
+2% +$4.71K ﹤0.01% 248
2025
Q4
$228K Buy
+4,159
New +$226K ﹤0.01% 228
2021
Q2
Sell
-9,174
Closed -$489K 178
2021
Q1
$489K Buy
+9,174
New +$502K 0.08% 111
2019
Q4
Sell
-16,841
Closed -$688K 191
2019
Q3
$688K Buy
16,841
+92
+0.5% +$3.8K 0.15% 81
2019
Q2
$719K Buy
16,749
+121
+0.7% +$5.14K 0.16% 79
2019
Q1
$714K Sell
16,628
-1,356
-8% -$57.1K 0.16% 84
2018
Q4
$702K Sell
17,984
-31,944
-64% -$1.28M 0.26% 34
2018
Q3
$2.14M Buy
49,928
+16,450
+49% +$710K 0.68% 21
2018
Q2
$1.45M Buy
+33,478
New +$1.55M 0.49% 26

Other funds holding EEM

Circle Wealth Management's EEM Position: Q2 2026 in Review

Circle Wealth Management reduced its iShares MSCI Emerging Markets ETF (EEM) stake by 12% in Q2 2026, selling an estimated $33.6K and leaving 3,725 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

Circle Wealth Management first reported a position in EEM in Q2 2018 and has held it in 10 quarters since. The position peaked at $2.14M in Q3 2018. 1,588 funds tracked by Wall St. Rank hold EEM as of Q2 2026.

  • Circle Wealth Management held 3,725 shares of iShares MSCI Emerging Markets ETF worth $255K as of Q2 2026.
  • Circle Wealth Management sold 514 iShares MSCI Emerging Markets ETF shares in Q2 2026, an estimated $33.6K.
  • iShares MSCI Emerging Markets ETF made up ﹤0.01% of Circle Wealth Management's portfolio in Q2 2026, its #235 holding.
  • Circle Wealth Management first reported a position in iShares MSCI Emerging Markets ETF in Q2 2018 and has held it in 10 quarters since.
  • Circle Wealth Management's iShares MSCI Emerging Markets ETF position peaked at $2.14M in Q3 2018.
  • 1,588 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q2 2026.

Based on Circle Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.